Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is International Biotechnology Trust PE Ratio (TTM)?
International Biotechnology TrustLSE:IBT +0.46%36 PE Ratio (TTM) is 4.52 as of Jul. 26, 2026, which is 36% below its 10-year median of 7.11. GuruFocus rates LSE:IBT with a GF Score™ of 36/100. The stock has 4 warning signs investors should review. Among 270 Biotechnology companies, International Biotechnology Trust ranks better than 88.52% on this metric.
International Biotechnology Trust (LSE:IBT) PE Ratio (TTM) Explanation
The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.
In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.
If a company loses money, the PE Ratio (TTM) becomes meaningless.
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.
Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.
Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .
PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).
International Biotechnology Trust PE Ratio (TTM) Related Terms
International Biotechnology Trust PE Ratio (TTM) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
International Biotechnology Trust PE Ratio (TTM) Chart
LSE:IBT vs VRTX, REGN, RVMD: PE Ratio (TTM) Comparison
For the Biotechnology subindustry, International Biotechnology Trust's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
International Biotechnology Trust PE Ratio (TTM) vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, International Biotechnology Trust's PE Ratio (TTM) distribution charts can be found below:
* The bar in red indicates where International Biotechnology Trust's PE Ratio (TTM) falls into.
International Biotechnology Trust PE Ratio (TTM) Calculation
The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.
International Biotechnology Trust's Share Price of today is £10.85.
For company reported semi-annually, International Biotechnology Trust's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was £2.40.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.
In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.
International Biotechnology Trust (LSE:IBT) has a PE Ratio (TTM) of 4.52 as of Jul. 26, 2026. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on International Biotechnology Trust and its competitors. This is 36% below median its historical median of 7.11. Over the past decade, International Biotechnology Trust's PE Ratio (TTM) has ranged from 2.78 to 42.14. According to the industry distribution chart, International Biotechnology Trust ranks #31 out of 270 companies in the Biotechnology industry, placing it in the top 11.5%.
Is International Biotechnology Trust's PE Ratio (TTM) too high?
International Biotechnology Trust's current PE Ratio (TTM) of 4.52 is 36% below median its 10-year median of 7.11. Over the past 10 years, this metric has ranged from a low of 2.78 to a high of 42.14. The Biotechnology industry median PE Ratio (TTM) is 26.76. International Biotechnology Trust's value of 4.52 is 83.1% below this industry median. Based on the distribution chart, International Biotechnology Trust ranks #31 out of 270 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, International Biotechnology Trust has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does International Biotechnology Trust's PE Ratio (TTM) compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, International Biotechnology Trust ranks #31 out of 270 companies for PE Ratio (TTM). This places International Biotechnology Trust in the top 12% of its industry — outperforming the majority of peers. The industry median PE Ratio (TTM) is 26.76. International Biotechnology Trust's value of 4.52 is 83.1% below this benchmark. Historically, International Biotechnology Trust's own PE Ratio (TTM) has ranged from 2.78 to 42.14 over the past decade. While the company's 10-year median is 7.11 vs. the industry median of 26.76, International Biotechnology Trust has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio (TTM) for a Biotechnology company?
The median PE Ratio (TTM) among Biotechnology companies is 26.76, based on 270 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio (TTM) significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. International Biotechnology Trust's current PE Ratio (TTM) of 4.52 is 83.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio (TTM) mean?
A high PE Ratio (TTM) can signal that a stock is expensive relative to its fundamentals. Trailing 12-month P/E ratio is the ratio of share price to a company's trailing 12-month earnings per share. View historical data on International Biotechnology Trust and its competitors. For the Biotechnology industry, the median PE Ratio (TTM) is 26.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. International Biotechnology Trust's current PE Ratio (TTM) is 4.52, which is 36% below median its own 10-year median of 7.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is International Biotechnology Trust stock overvalued right now?
International Biotechnology Trust (LSE:IBT) has a current PE Ratio (TTM) of 4.52. The current PE Ratio (TTM) is 4.52, which is 36% below median its 10-year median of 7.11 and 83.1% below the Biotechnology industry median of 26.76. International Biotechnology Trust's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio (TTM) calculated?
PE Ratio (TTM) is calculated from a company's financial statements. For International Biotechnology Trust (LSE:IBT), the current PE Ratio (TTM) is 4.52 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
International Biotechnology Trust Business Description
International Biotechnology Trust PLC is an investment trust company. It aims at achieving long-term capital growth by investing in biotechnology and other life sciences companies. It seeks to achieve its objective by investing in a diversified portfolio of companies which has good growth prospects. It focuses on investments in biotechnology companies which are engaged in on drug discovery and development, medical devices companies and healthcare services provider. The invests in various financial instruments such as equities, index-linked securities, debt securities, cash deposits, money market instruments ,and foreign currency exchange transactions. Its revenue comprises of dividend, interest and other income from investment made.
36GF Score
Get the complete analysis for LSE:IBT
PE Ratio (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:IBT has been successfully added to your 
